Where Does Rhythm Pharmaceuticals Inc (RYTM) Stock Fall in the Biotechnology Field After It Is Up 16.16% This Week?

Rhythm Pharmaceuticals Inc (RYTM) is near the top in its industry group according to InvestorsObserver. RYTM gets an overall rating of 72. That means it scores higher than 72 percent of stocks. Rhythm Pharmaceuticals Inc gets a 92 rank in the Biotechnology industry. Biotechnology is number 51 out of 148 industries.

RYTM has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on RYTM!

See Full RYTM Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 72 means the stock is more attractive than 72 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Rhythm Pharmaceuticals Inc Stock Today?

Rhythm Pharmaceuticals Inc (RYTM) stock is trading at $33.06 as of 12:26 PM on Friday, Nov 17, an increase of $0.60, or 1.85% from the previous closing price of $32.46. The stock has traded between $32.47 and $33.30 so far today. Volume today is light. So far 163,372 shares have traded compared to average volume of 589,729 shares. Click Here to get the full Stock Report for Rhythm Pharmaceuticals Inc stock.